Patents by Inventor Jinming Zhou
Jinming Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250105716Abstract: Embodiments of the disclosure provide a stator module and a conveyor system. The stator module includes a stator body and an armature winding, wherein the armature winding is fixedly arranged on the stator body, the armature winding is provided with an upper surface and a lower surface which are oppositely arranged in a first direction, and a first splicing surface and a second splicing surface which are oppositely arranged in a second direction perpendicular to the first direction, the armature winding is provided with a first protrusion, and the first protrusion protrudes from the first splicing surface in the second direction, wherein the armature winding is provided with a plurality of armature coils arranged periodically, and at least part of the plurality of the armature coils are arranged in the first protrusion.Type: ApplicationFiled: March 3, 2023Publication date: March 27, 2025Inventors: Feng CHI, Lin GUO, Jinming ZHOU
-
Patent number: 12168465Abstract: Disclosed is a gearbox for rail vehicle, a bogie for rail vehicle and a rail vehicle. The gearbox for rail vehicle includes a primary gearbox (1) configured to connect with a traction motor, and a secondary gearbox (2) arranged on both sides of the primary gearbox (1) along a longitudinal direction of the rail vehicle, wherein a framework bearing beam is formed by connecting the primary gearbox (1) and the secondary gearbox (2), the primary gearbox (1) is configured to transmit power from the traction motor to the secondary gearbox (2), and the secondary gearbox (2) are configured to transmit power from the primary gearbox (1) to wheelsets of the rail vehicle.Type: GrantFiled: May 18, 2020Date of Patent: December 17, 2024Assignee: CRRC QINGDAO SIFANG CO., LTD.Inventors: Shuliang Song, Zhen Chang, Yuejun Zhang, Jinming Zhou, Tianyi Li
-
Publication number: 20230321079Abstract: The present invention provides use of berbamine dihydrochloride in preparation of an Ebola virus inhibitor. In the present invention, the primed glycoprotein of the Ebola virus (EBOV-GPcl) is taken as a target site, and an antiviral active compound with the capability of binding to the EBOV-GPcl, i.e., berbamine dihydrochloride, is obtained through structure-based virtual screening. Berbamine dihydrochloride can specifically inhibit the entry of an Ebola recombinant virus by binding to the target protein EBOV-GPcl, thereby achieving the effect of anti-Ebola virus infection. The half-maximum effect concentration (EC50) of berbamine dihydrochloride against EBOV is 0.49 ?M, which indicates that berbamine dihydrochloride has a strong inhibition effect on EBOV.Type: ApplicationFiled: April 10, 2023Publication date: October 12, 2023Inventors: Shan Cen, Quanjie Li, Dongrong Yi, Yi Shi, Han Wang, Jinming Zhou
-
Patent number: 11654141Abstract: The present invention provides use of berbamine dihydrochloride in preparation of an Ebola virus inhibitor. In the present invention, the primed glycoprotein of the Ebola virus (EBOV-GPcl) is taken as a target site, and an antiviral active compound with the capability of binding to the EBOV-GPcl, i.e., berbamine dihydrochloride, is obtained through structure-based virtual screening. Berbamine dihydrochloride can specifically inhibit the entry of an Ebola recombinant virus by binding to the target protein EBOV-GPcl, thereby achieving the effect of anti-Ebola virus infection. The half-maximum effect concentration (EC50) of berbamine dihydrochloride against EBOV is 0.49 ?M, which indicates that berbamine dihydrochloride has a strong inhibition effect on EBOV.Type: GrantFiled: June 19, 2019Date of Patent: May 23, 2023Assignee: Institute of Medicinal Biotechnology, Chinese Academy of Medical SciencesInventors: Shan Cen, Quanjie Li, Dongrong Yi, Yi Shi, Han Wang, Jinming Zhou
-
Publication number: 20220212697Abstract: Disclosed is a gearbox for rail vehicle, a bogie for rail vehicle and a rail vehicle. The gearbox for rail vehicle includes a primary gearbox (1) configured to connect with a traction motor, and a secondary gearbox (2) arranged on both sides of the primary gearbox (1) along a longitudinal direction of the rail vehicle, wherein a framework bearing beam is formed by connecting the primary gearbox (1) and the secondary gearbox (2), the primary gearbox (1) is configured to transmit power from the traction motor to the secondary gearbox (2), and the secondary gearbox (2) are configured to transmit power from the primary gearbox (1) to wheelsets of the rail vehicle.Type: ApplicationFiled: May 18, 2020Publication date: July 7, 2022Inventors: Shuliang SONG, Zhen CHANG, Yuejun ZHANG, Jinming ZHOU, Tianyi LI
-
Publication number: 20210091964Abstract: The invention discloses a physically unclonable structural-color anti-counterfeiting label with artificial intelligence (AI) authentication, which is formed by doping micron-sized particles into disorderedly arranged monodisperse submicron-sized particles and coating onto a black substrate; alternatively, by doping micron-sized particles and black nanoparticles into disorderedly arranged monodisperse submicron-sized particles and coating onto a substrate. The disordered arrangement of monodisperse submicron-sized microspheres has a special effect on light to make the anti-counterfeiting label show a specific structural color. AI is used to learn the anti-counterfeiting label images obtained from an optical microscope and memorize their structural characteristics to form an anti-counterfeiting label database.Type: ApplicationFiled: August 24, 2020Publication date: March 25, 2021Inventors: Jinming Zhou, Xueying He, Yanan Gu, Heling Zhu
-
Publication number: 20200281916Abstract: The present invention provides use of berbamine dihydrochloride in preparation of an Ebola virus inhibitor. In the present invention, the primed glycoprotein of the Ebola virus (EBOV-GPcl) is taken as a target site, and an antiviral active compound with the capability of binding to the EBOV-GPcl, i.e., berbamine dihydrochloride, is obtained through structure-based virtual screening. Berbamine dihydrochloride can specifically inhibit the entry of an Ebola recombinant virus by binding to the target protein EBOV-GPcl, thereby achieving the effect of anti-Ebola virus infection. The half-maximum effect concentration (EC50) of berbamine dihydrochloride against EBOV is 0.49 ?M, which indicates that berbamine dihydrochloride has a strong inhibition effect on EBOV.Type: ApplicationFiled: June 19, 2019Publication date: September 10, 2020Applicant: INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCESInventors: Shan CEN, Quanjie LI, Dongrong YI, Yi SHI, Han WANG, Jinming ZHOU
-
Patent number: 10507847Abstract: A central traction device for a straddling monorail train includes a traction pin and a traction beam. A central sleeve is provided at the center of the traction beam, and the traction pin is mounted in the central sleeve. An inner cavity of the central sleeve has a corset-shaped structure having large diameters on an upper end and a lower end and a small diameter at a middle part, forming double tapered bevels, and a resilient rubber bush is provided between an inner wall of the central sleeve and the traction pin. The device has a simple and compact overall structure and facilitates connection and separation between the train body and the bogie; by providing the lift assembly, the traction device is fixedly connected to the frame, thus the traction device can be wholly lifted; and operation process and environment of raising and lowering the vehicle are improved.Type: GrantFiled: December 13, 2016Date of Patent: December 17, 2019Assignee: CRRC QINGDAO SIFANG CO., LTD.Inventors: Jinming Zhou, Yuejun Zhang, Huijie Zhang, Lijun Ma, Xiaojun Lv, Haiqin Zhao, Xiaojiang Zhou, Shuliang Song, Wei Zhao, Yujie Shi, Chaozhi Zhai
-
Publication number: 20180345996Abstract: A central traction device for a straddling monorail train includes a traction pin and a traction beam. A central sleeve is provided at the center of the traction beam, and the traction pin is mounted in the central sleeve. An inner cavity of the central sleeve has a corset-shaped structure having large diameters on an upper end and a lower end and a small diameter at a middle part, forming double tapered bevels, and a resilient rubber bush is provided between an inner wall of the central sleeve and the traction pin. The device has a simple and compact overall structure and facilitates connection and separation between the train body and the bogie; by providing the lift assembly, the traction device is fixedly connected to the frame, thus the traction device can be wholly lifted; and operation process and environment of raising and lowering the vehicle are improved.Type: ApplicationFiled: December 13, 2016Publication date: December 6, 2018Applicant: CRRC QINGDAO SIFANG CO., LTD.Inventors: Jinming ZHOU, Yuejun ZHANG, Huijie ZHANG, Lijun MA, Xiaojun LV, Haiqin ZHAO, Xiaojiang ZHOU, Shuliang SONG, Wei ZHAO, Yujie SHI, Chaozhi ZHAI
-
Patent number: 8470889Abstract: The present invention relates to the synthesis of a series of ionone and curcumin derivatives as multi-targeting agents effective against both hormone-sensitive and hormone-independent cancers. In particular, the present invention is directed to a distinct class of bifunctional antiandrogens, which inhibit both AR and IKBkinases (IKK). A series of ionone-based chalcones were synthesized and their in vitro cytotoxicity against prostate cancer cell lines were demonstrated. A series of derivatives formed by reacting ionone-based chalcones and hydrazines demonstrate substantial antiproliferative activities in prostate cancer, breast cancer and lung cancer cell lines.Type: GrantFiled: November 25, 2009Date of Patent: June 25, 2013Assignee: TRT Pharma Inc.Inventors: Jian Hui Wu, Gérald Batist, Jinming Zhou, Guoyan Geng, Rongtuan Lin, Yi Li
-
Publication number: 20110230488Abstract: The present invention relates to the synthesis of a series of ionone and curcumin derivatives as multi-targeting agents effective against both hormone-sensitive and hormone-independent cancers. In particular, the present invention is directed to a distinct class of bifunctional antiandrogens, which inhibit both AR and IKBkinases (IKK). A series of ionone-based chalcones were synthesised and their in vitro cytotoxicity against prostate cancer cell lines were demonstrated. A series of derivatives formed by reacting ionone-based chalcones and hydrazines demonstrate substantial antiproliferative activities in prostate cancer, breast cancer and lung cancer cell lines.Type: ApplicationFiled: November 25, 2009Publication date: September 22, 2011Applicant: TRT PHARMA INC.Inventors: Jian Hui Wu, Gerald Batist, Jinming Zhou, Guoyan Geng, Rongtuan Lin
-
Patent number: D1072752Type: GrantFiled: March 2, 2023Date of Patent: April 29, 2025Inventors: Feng Chi, Lin Guo, Jinming Zhou